PDL BioPharma has named Faheem Hasnain President and CEO
Anthony S. Marucci has been appointed President and CEO of Avant Immunotherapeutics (now Celldex Therapeutics)
Daniel M. Junius, currently President and COO ImmunoGen, will become President and CEO
Inotek Pharmaceuticals has appointed Paul G. Howes President and CEO
Charles H. Seeman has been appointed CFO and Executive VP, Finance and Administration of Oxygen Biotherapeutics
Roland Toder, Ph.D., has stepped down as CEO of Vivendy Therapeutics
Molecular Insight Pharmaceuticals has appointed John W. Babich, Ph.D., as interim CEO
4-Antibody has appointed Dr. Richard Mason as CEO
Pfizer's George Rathbun has been named Chief Technology Officer of CRIX International
Alnylam Pharmaceuticals has appointed John Schmidt As Chief Scientific Officer
Koronis Pharmaceuticals has appointed Jeff Parkins as VP, Clinical Development
Dr. Stephen Game has been named Head of Research and Development at Genetix
Vanguard Pharmaceutical has appointed Raul Fernandez president
Michael Slater has replaced Dennis Bucceri as SVP Regulatory Affairs and Operations at Acusphere
Dennis Kim, M.D. has been named Senior VP, Obesity and Metabolic Disorders of Orexigen Therapeutics
Tekmira Pharmaceuticals has added Tammy Mullarky as Vice President, Strategic Planning and Business Development and Dr. Peter Lutwyche as Vice President, Pharmaceutical Development
John Celentano, Bristol-Myers Squibb's representative on Imclone's board, has resigned